27 April 2021

BAP Pharma Limited sign an exclusive agreement for the supply and distribution of Bicillin® LA (Penicillin G Benzathine pre-filled syringe) to treat patients with bacterial infections in the UK and Europe.

BAP Pharma Limited is pleased to announce the signing of an exclusive agreement for the supply and distribution of Bicillin® L-A (Penicillin G Benzathine) to expand access to the product in the UK and Europe (previously only available in the US)


Product Details

Bicillin® L-A is a ready-to-use Benzathine Benzylpenicillin, also known as Penicillin G Benzathine (PBG) slow-onset, long-acting antibiotic in prefilled syringes that fights bacteria in the body.

Bicillin® L-A belongs to the group of penicillin antibiotics and works by killing bacteria or preventing their growth. This particular type of Bicillin is called Bicillin® L-A because it is long-acting.

Bicillin® L-A is supplied as a prefilled syringe in a pack of ten, for single use only.


Product Usage

Bicillin® L-A is used to treat a wide variety of venereal bacterial infections in different parts of the body caused by bacteria, such as Syphilis, Yaws, Bejel and Pinta, as well as Rheumatic Fever and/or Chorea.


Product Approval

Bicillin® L-A (Penicillin G Benzathine) has received approval from the Food and Drug Administration (FDA)


For More Information

To obtain additional information regarding Bicillin® LA (Penicillin G Benzathine) Expanded Access Program, please contact our Medicines Access team at: [email protected] or call: 01753 980250.


BAP Pharma Limited

BAP Pharma are global leaders in clinical trial supply, specialising in Medicines Access, Comparator Sourcing and Secondary Packaging & Labelling.

We work with our clients to provide bespoke solutions to ensure patients can gain access to the treatment they require through commercial supply or on a named patient basis. Our extensive experience in the pharmaceutical industry and our global storage and distribution capabilities, allows us to fully understand customer supply needs and truly deliver on our promise.


‘Promise Delivered’


Our focus is on delivering a high-quality, well-informed service to customers, ensuring that we proactively manage the whole supply from start to finish, using quality partners. This ensures products are received in the perfect condition.

BAP Pharma’s added value assures clients that our dedicated team will provide innovative solutions. This allows compliant and uncomplicated access to their product and maximises the potential of their product at the Pre- and Post-Approval stage. This increases patient access to sought-after medicines that were previously unavailable.

The BAP Pharma group have headquarters in the UK, Germany & USA and partners with storage facilities across the world, which gives us a true global reach.

You Might Also Like

Walk All Over Cancer Challenge 2021

At the beginning of March 2021, a group of volunteers came together from BAP Pharma Ltd, to form the BAP Steppers. Their aim – to take on the Walk All Over Cancer challenge for Cancer Research UK. The BAP Steppers put on their walking shoes and braved the unpredictable weather,

Walk All Over Cancer Challenge 2021

Minority Supplier Development UK Report 2021

We are excited and proud to announce that BAP Pharma have ranked 78th in the Minority Supplier Development UK Report 2021 – the first ever list of the country’s top 100 minority businesses. The Minority Supplier Development UK (MSDUK) is the UK’s premier not-for-profit membership organisation, championing diversity and inclusion

Minority Supplier Development UK Report 2021

The Sunday Times International Track 200

We are delighted to announce that BAP Pharma have ranked in the top 50% (97th) in the 12th annual Sunday Times HSBC International Track 200. The Sunday Times HSBC International Track 200 ranks Britain’s mid-market private companies with the fastest-growing international sales, measured over their latest two years of available

The Sunday Times International Track 200